Dr. Tomasz P. Srokowski, M.D.
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Medical school
- Washington University School of Medicine (2003)
- Years since graduation
- 23
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 338
Licensed in Illinois since 2009, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2003Medical school: Washington University School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
IL license 036123860 (first issued 2009; active) -
Internal Medicine Physician
IL license 036123860 (first issued 2009; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Memorial Medical Center Springfield, IL
- St Johns Hospital Springfield, IL
- Taylorville Memorial Hospital Taylorville, IL
- Abraham Lincoln Memorial Hospital Lincoln, IL
- Jacksonville Memorial Hospital Jacksonville, IL
Medical groups
- Springfield Clinic, LLP (687 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 338
- Services billed
- 120,205
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Injection, ferric carboxymaltose, 1 mg | 24,750 | 16 |
| Injection, pembrolizumab, 1 mg | 11,000 | 13 |
| Injection, dexamethasone sodium phosphate, 1 mg | 1,304 | 31 |
| Injection, palonosetron hcl, 25 mcg | 810 | 23 |
| Insertion of needle into vein for collection of blood sample | 487 | 150 |
| Infusion, normal saline solution, 250 cc | 388 | 74 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 380 | 135 |
| Established patient office or other outpatient visit, 30-39 minutes | 310 | 108 |
| Established patient office or other outpatient visit, 20-29 minutes | 279 | 185 |
| Administration of chemotherapy into vein, 1 hour or less | 226 | 53 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ondansetron Hcl Other prescribers in Springfield, IL | 88 |
| Anastrozole Other prescribers in Springfield, IL | 87 |
| Warfarin Sodium Other prescribers in Springfield, IL | 67 |
| Revlimid (lenalidomide) | 59 |
| Prednisone Other prescribers in Springfield, IL | 55 |
| Potassium Chloride Other prescribers in Springfield, IL | 51 |
| Valacyclovir (valacyclovir hcl) Other prescribers in Springfield, IL | 48 |
| Hydroxyurea Other prescribers in Springfield, IL | 43 |
| Dexamethasone Other prescribers in Springfield, IL | 42 |
| Alendronate Sodium Other prescribers in Springfield, IL | 39 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 14 companies reported 30 payments worth $724 in total to this clinician.
| Daiichi Sankyo Inc. | $121 |
|---|---|
| Novartis Pharmaceuticals Corporation | $104 |
| Pfizer Inc. | $98.68 |
| AbbVie Inc. | $81.53 |
| Merck Sharp & Dohme LLC | $58.30 |
| Incyte Corporation | $43.01 |
| AstraZeneca Pharmaceuticals LP | $38.40 |
| Janssen Biotech, Inc. | $37.25 |
| Food and Beverage | $663 |
|---|---|
| Education | $61.30 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Pfizer Inc. Aug 29, 2025 | Education IBRANCE · ONCOLOGY · in-kind | $30.65 |
| Pfizer Inc. Nov 5, 2025 | Education IBRANCE · ONCOLOGY · in-kind | $30.65 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.